Of 26 health systems surveyed by MedCity News, nearly half used automated tools to respond to the Covid-19 pandemic, but none of them were regulated. Even as some hospitals continued using these algorithms, experts cautioned against their use in high-stakes decisions.
President Joe Biden has submitted his discretionary budget for 2022 to Congress. Among its healthcare provisions are funding requests for the CDC, mental health and social determinants of health programs. But there are some unusual requests as well, such as funding for an Office of… Read More »Public health, racial equity, climate action drive Biden’s budget requests for healthcare
There should be a discussion about how to address the disproportionate impact Covid-19 has had on Black communities.
As part of the biopharmaceutical industry’s efforts to improve health outcomes for patients in underserved communities, PhRMA member companies are identifying ways to improve clinical trial diversity and reduce barriers to participation for Black and Brown communities. As these efforts continue to take shape, our… Read More »PhRMA member companies share how they are improving clinical trial diversity
If we don’t prioritize solutions now, the healthcare digital divide may present more widespread national and international challenges.
A group of healthcare stakeholders in Oregon signed a compact that aims to spread advanced value-based payment models across the state. Though it is not legally binding, the agreement sets a target to tie 70% of healthcare payments to value within the next four years.
Areas that have been hit hardest by the Covid-19 pandemic are falling short when it comes to vaccine access. Community leaders are pushing to bring vaccination sites to their neighborhoods.
To reduce the systemic health inequities that have put so many individuals at higher risk of getting sick and dying from Covid-19, healthcare organizations must leverage advanced technologies such as NLP to identify SDoH and other critical information from unstructured notes.
While telehealth use soared last year, the biggest increases were among adults living in metropolitan areas with low poverty levels, according to research published in the American Journal of Preventive Medicine.
MedCity News has assembled compelling speakers to address the Covid-prompted rapid transformation of healthcare at this year’s virtual INVEST conference, April 19-23.
Particularly at the point of care, we have the means and resources to directly inform, educate and offer service to those who have been marginalized across multiple demographic intersections of race, ethnicity and income.
Our industry has committed itself to making our workplaces trusting places to have complex, and sometimes difficult, conversations about diversity and inclusion.
COVID-19 has laid bare racial disparities in the United States health system. For example, COVID-19 cases among Native Hawaiian / Pacific Islanders are up to 2.5 times higher as compared to whites. Similarly, the rate of COVID-19 related deaths among Black Americans and American Indian/Alaskan… Read More »Paper finds gaps in health data are a barrier to health equity
As part of PhRMA’s continuing work to address health inequities, we are partnering with researchers to study hotspots of COVID-19 and chronic disease inequities in New York state. Reports this summer show that boroughs in New York City with the lowest per-person income and lowest… Read More »New research shows hotspots of inequity relate to increased COVID-19 hospitalizations
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view.
Today, PhRMA released a new report prepared by TEConomy Partners, LLC that provides insights into the efforts of biopharmaceutical companies to advance diversity & inclusion (D&I) in the workplace, in the communities in which they operate and in the patient communities in which they serve.… Read More »New report highlights biopharmaceutical industry’s commitment to D&I
This year our industry has been working around the clock to combat the COVID-19 virus, including developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections. Outside of the novel coronavirus, major social issues have been brought to the forefront of public discourse.… Read More »Strengthening a culture dedicated to patients and equity: A conversation with Percival Barretto-Ko, President of Astellas US
Systemic racism is as real as any disease, and our industry is not immune. This summer, in the wake of a national outcry for racial and social justice, our industry offered a firm stance – systemic racism is a disease. As a pharmacist and public… Read More »PhRMA CAREs Grant request for proposals: Addressing racial disparities in medication utilization and adherence
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view.
Yesterday, PhRMA published first ever industry-wide principles on clinical trial diversity, a new chapter in the already existing “Principles on Conduct of Clinical Trials & Communication of Clinical Trial Results.” These new principles have been approved by the PhRMA Board of Directors and will take… Read More »Just released: PhRMA members’ new clinical trial diversity principles
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view.
Even though Covid-19 is distinct from any health crisis the country has previously faced, assessing U.S. public health strategies during past crises can provide insight into what has contributed to a more or less equitable response.
Critics have faulted some technologies for potentially reinforcing racial inequality. But a Deloitte exec painted a more optimistic picture at the HLTH conference.
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. Today, we are pleased to welcome a guest post from Jason Resendez who is the executive director of the UsAgainstAlzheimer’s Center… Read More »Guest Post: Honoring Hispanic Heritage Month by taking action on health equity
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Today, we… Read More »Sharing rebates can improve access to medicines and increase health equity
In rearchitecting the system by training every care provider in every specialty, and enable lower-cost providers and communities, we will provide a new model of care where a physician isn’t the person who helps us when we’re sick — they help us be healthy.
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Today, we… Read More »Guest Post: Amgen Foundation stands for equal opportunities in STEM learning
This month, PhRMA published our commitment to racial equity and inclusion in the New York Times as well as in the Informer and the AfroAmerican, DC-based, Black-owned newspapers. This public declaration is an important milestone for our industry as we continue to take concrete steps… Read More »Systemic racism is as real as any disease, and our industry is not immune
The post Navigating systemic racism in Canadian healthcare appeared first on Healthy Debate.
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Today, we… Read More »Guest Post: Pride started with protest: Combatting the dual pandemics of COVID-19 and racism this Pride Month